Trial intelligence / Profile preview

PRP and Hyaluronic Acid in Knee Osteoarthritis

NCT02923310Phase 2Unknown

Sponsor
Universidade Estadual de Campinas
Start
Nov 2013
Primary completion
Sep 2016
Modality
Adipose-derived MSCs, Bone Marrow MSCs
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of platelet-rich plasma and Leukocyte-Rich Platelet-Rich Plasma in osteoarthritis (OA), sponsored by Universidade Estadual de Campinas. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 1 year. Status: unknown.

02

Drugs

platelet-rich plasmaLeukocyte-Rich Platelet-Rich Plasma
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02923310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02923310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call